Literature DB >> 2736990

Indications for surgery based on lung biopsy in cases of ventricular septal defect and/or patent ductus arteriosus with severe pulmonary hypertension.

S Yamaki1, H Mohri, K Haneda, M Endo, H Akimoto.   

Abstract

Pathologic obstruction of the proximal lumen and secondary atrophy of the media of the peripheral small pulmonary arteries were absolute operative contraindications in cases of VSD and/or PDA with severe pulmonary hypertension. Such patients who were operated on died with no decrease in pulmonary arterial pressure. The index of pulmonary vascular disease (IPVD), a composite and quantitative evaluation of the severity of pulmonary vascular disease, was introduced to determine the operability of other patients. An IPVD rating of 2.2 in Down's syndrome and 2.1 without the syndrome were regarded as the upper permissible limits for surgical intervention based on results of 23 autopsies and 26 lung biopsies of patients operated on before 1981. Open lung biopsy was performed in 51 patients to determine applicability of our operative indications. Twenty-nine cases were considered operable by our criteria, and 28 underwent surgical correction without operative or late death. Twenty-two cases thought inoperable remain under observation. Comparative analysis of the pathology and preoperative hemodynamic data suggested that lung biopsy should be carried out to determine operability in cases with pulmonary vascular resistance greater than 8 units.m2.

Entities:  

Mesh:

Year:  1989        PMID: 2736990     DOI: 10.1378/chest.96.1.31

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Progressive pulmonary vascular disease after pulmonary artery banding and total correction in a case of ventricular septal defect and pulmonary hypertension.

Authors:  S Yamaki; S Yonesaka; S Suzuki; K Nagumo; K Ouchi; T Takahashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-05

2.  Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension.

Authors:  Zhuoyuan Xu; Michael A Gatzoulis; Konstantinos Dimopoulos; Qiangqiang Li; Chen Zhang; Bradley B Keller; Hong Gu
Journal:  CJC Open       Date:  2021-02-17

3.  Patent ductus arteriosus closure using an Amplatzer(™) ventricular septal defect closure device.

Authors:  Rajeev Fernando; Ketan Koranne; Pranav Loyalka; Biswajit Kar; Igor Gregoric
Journal:  Exp Clin Cardiol       Date:  2013

4.  A rare case of large ventricular septal defect with minimal pulmonary vascular obstructive changes in a 41-year-old woman.

Authors:  K Sadamatsu; Y Harasawa; K Ozono; T Yasutsune; M Masuda; Y Kawachi; H Yasui; A Takeshita
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

5.  Indications for open lung biopsy in patients with ventricular septal defect and/or patent ductus arteriosus with pulmonary hypertension.

Authors:  S Yamaki; H Ogata; K Haneda; H Mohri
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

6.  Pulmonary vascular disease associated with pulmonary hypertension in 445 patients: diagnosis from lung biopsy and autopsy.

Authors:  Shigeo Yamaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-26

7.  Clinical features and outcome of dogs and cats with bidirectional and continuous right-to-left shunting patent ductus arteriosus.

Authors:  Victoria Greet; Elizabeth F Bode; Joanna Dukes-McEwan; Pedro Oliveira; David J Connolly; Julia Sargent
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

8.  Atrial septal defect with borderline pulmonary vascular disease: surgery and long-term oral prostacyclin therapy for recalcitrant pulmonary hypertension.

Authors:  Hitoshi Yamauchi; Shigeo Yamaki; Masahiro Fujii; Yoshiaki Saji; Masami Ochi; Kazuo Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.